Scope of the Study
Newborn screening is the preparation of testing all babies in their first days of life for certain disorders and conditions that can impede their normal development. The newborn screening testing is required in every state and is typically performed before the baby leaves the hospital. The conditions comprised in newborn screening can cause serious health complications starting in infancy or childhood. Early detection and treatment can help avert intellectual and physical infirmities and life-threatening illnesses. However, the lack of uniformity of newborn testing policies and procedures across the world is hampering market growth.
The market study is being classified by Type (Pulse Oximeter, Mass Spectrometer, Hearing Screening Devices, Laparoscopes, Retinoscopes, Ultrasound Machines and Others), by Application (Dry Blood Spot Test, Critical Congenital Heart Disease (CCHD), Hearing Screen, Urine Test and Others) and major geographies with country level break-up.
PerkinElmer (United States), Waters Corporation (United States), Natus Medical (United States), GE Healthcare (United States), AB Sciex (United States), Thermo Fisher Scientific (United States), Trivitron Healthcare (India), Agilent Technologies (United States), Bio-Rad Laboratories (United States) and Medtronic plc (Ireland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Masimo (United States) and ZenTech SA (Belgium).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Newborn Screening Instruments market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Newborn Screening Instruments market by Type, Application and Region.
On the basis of geography, the market of Newborn Screening Instruments has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Benefits Related to Newborn Screening
- Regulations and Mandates Demand the Implementation of Newborn Testing Programs
- Technological Innovations in Newborn Screening Instruments
- Lack of Professional Infrastructure
- High Growth in Screening of Genetic Disorders
- Lack of Uniformity of Newborn Testing Policies and Procedures Worldwide
The Screening for Heritable Disorders Legislation was created to enhance, improve, and expand the ability of state and local public health agencies to provide screening, counseling, and health care services to newborns and children who have, or are at risk for, heritable disorders. This legislation established the Heritable Disorders Program and created the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). In 2008, The Newborn Screening Saves Lives Act (H.R. 3825, S. 1858) was enacted to amend the Heritable Disorders Program legislation. This added several programs and further defined the activities for ACHDNC.
Key Target AudienceManufacturers of Newborn Screening Instruments, Suppliers of Raw Materials, Wholesalers and Distributors of Newborn Screening Instruments, Healthcare Industry, Governmental Bodies and Research Organization
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase